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Purpose

• The decision was made to perform a PSAE. The
lower to mid portions of the spleen were
embolized with 500-700 micrometer particles
followed by gelfoam mixed with gentamicin 80
mg until stasis was achieved. Final run DSA
showed 70-80% of the splenic parenchyma was
embolized with 20-30 % residual arterial supply
(Figure 2).

• To present a novel case of splenic artery
embolization to treat idiopathic warm
autoimmune hemolytic anemia refractory to
medical therapy.

Background
• While Partial Splenic Artery Embolization (PSAE) is a
useful procedure that has been performed for a variety of
indications including trauma and hypersplenism, it has only
been rarely described as a treatment for idiopathic warm
Autoimmune Hemolytic Anemia (AIHA).

• Following the procedure, the patient’s remained
clinically stable and his hemoglobin continued to
trend upwards until it stabilized at 6 g/dl.

• Warm AIHA is caused by increased red blood cell (RBC)
destruction triggered by antibodies reacting against RBC
surface antigens. It is the most common form of AIHA. First
line therapy for warm AIHA consists of corticosteroids.
• For cases that are refractory to steroid management, the
current management for second line therapy is splenectomy,
rituximab, and if these fail, alternative immunosuppressive
medications.

Figure 1: CT abdomen showed an enlarged
spleen with a span of 16.5 cm in its maximum
dimension

Figure 2: A) Pre-embolization angiography of the splenic artery showing the three lower
branches to be embolized (asterisks) B) Post embolization angiography of the splenic
artery with 20-30% residual blood supply to the superior pole

Case Report
•

•

•

•

A 27-year-old male with a history of warm AIHA who
presented with two day history of nausea, vomiting,
and epigastric pain. His exam was significant for scleral
icterus and sublingual jaundice. Laboratory workup
showed a low hemoglobin of 5.5 g/dl and hematocrit of
15.7 %. Haptoglobin: <8 g/dl (low). He was started on
intravenous methylprednisolone 1g/day.

• After embolization, the patient remained inpatient
for 8 days for close observation. Laboratory
workup also showed increasing haptoglobin, and
decreasing LDH (Figure 3).
• The patient was scheduled for an elective
splenectomy approximately 3 months after the
embolization procedure. There were no surgical
complications.

Conclusion
• In conclusion, our case shows the utility
of PSAE as an acute life-saving
intervention for a poor surgical candidate
with idiopathic warm AIHA refractory to
medical therapy as a bridge to definitive
splenectomy.

Prior to presentation at our institution the patient was
managed at an outside hospital where he received
corticosteroids, an immunosuppressant, and twelve
transfusions. The patient was transferred to our
institution for escalation of care after developing
autoantibodies that precluded future administration of
transfusions.
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